|
Volumn 21, Issue 5, 1996, Pages 476-479
|
Naratriptan. Treatment of migraine, 5-HT(1D) agonist
a a
a
PROUS SCIENCE
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NARATRIPTAN;
SEROTONIN 1 AGONIST;
SEROTONIN 1D RECEPTOR;
SUMATRIPTAN;
ANIMAL EXPERIMENT;
ARTICLE;
BRAIN BLOOD VESSEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOG;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
GUINEA PIG;
HEADACHE;
HUMAN;
HUMAN EXPERIMENT;
MALE;
MIGRAINE;
NONHUMAN;
NORMAL HUMAN;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR AFFINITY;
SKIN TINGLING;
SUBCUTANEOUS DRUG ADMINISTRATION;
SWINE;
VASOCONSTRICTION;
|
EID: 0030035660
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1996.021.05.356029 Document Type: Article |
Times cited : (8)
|
References (0)
|